On the certificates published at www.primesciencesupply.com/certificates there is a line most readers skip. It sits between the sodium ion line and the peptide purity line. On the GHK-Cu certificate — document COA-PBL-010326-GHKCU, lot GHKCU-122825 — it reads:
Trifluoroacetic Acid (TFA) · Specification: NMT 0.10% · Method: HPLC · Result: Conforms
The only number among the four fields is in the Specification column. The Result column contains a word. This piece is about what that line measures, what it does not, and why the difference is less obvious than it looks.
TFA is not an accident of handling
Trifluoroacetic acid (CF₃COOH, molecular weight 114.02 g/mol per PubChem CID 6422) is a reagent of the method, not a stray contaminant. In Fmoc solid-phase peptide synthesis it is the global deprotection and cleavage agent that releases the finished chain from the resin, and it reappears downstream as the standard ion-pairing additive in reversed-phase liquid chromatography — the same technique that produces the purity percentage printed two lines below it on the same page.
The number that certifies purity and the substance being limited come out of the same process. A supplier who publishes an HPLC purity figure and no TFA line has not thereby shown the material to be free of TFA. A missing line is a missing measurement, not a missing substance.
Volatile, and it still stays
TFA boils at 72.4 °C (PubChem CID 6422, citing the Merck Index), which makes the intuition reasonable: lyophilization should carry it off. The free acid, largely yes. What remains is the part that is not free — TFA deprotonates, and the trifluoroacetate anion pairs with the basic sites of the peptide (lysine, arginine and histidine side chains, and the N-terminal amine) and leaves the freeze-dryer as a salt, inside the powder, on the balance.
How much stays is a property of the sequence. In Pharmaceuticals (2025), Erckes and colleagues measured 0.333 ± 0.008 mg of trifluoroacetate per mg of peptide salt for one of the peptides they characterized, and reported TFA in excess of what charge stoichiometry alone predicts.
Now hold two numbers next to each other: a certificate limit of NMT 0.10%, and a published counterion load in the tens of percent. They cannot be describing the same quantity.
The question the line does not answer
A residual-solvent limit and a counterion determination are different measurements. The first asks how much unbound acid survived drying. The second asks what fraction of the vial's mass is trifluoroacetate rather than peptide. Both are called "TFA content" in ordinary use, and a line reading Trifluoroacetic Acid — NMT 0.10% does not say which of the two it ran.
So the useful question is not "is the TFA low?" It is: free-acid limit, or counterion determination — and by what method? Ion chromatography with suppressed conductivity detection (Kaiser and Rohrer, Journal of Chromatography A, 2004) and ¹⁹F NMR each quantify trifluoroacetate directly. "HPLC" standing alone in a Method column does not identify which question was put to the sample.
We publish what we receive. What we receive on this line is a specification and the word Conforms — a pass against a threshold, not a position inside it.
Why USP <467> does not settle it
The same certificate carries a separate line: Residual Solvents · Meets USP <467> · GC per USP <467> · Conforms. It is tempting to read that as covering TFA as well. It does not.
USP <467> reproduces the ICH solvent tables, and trifluoroacetic acid appears in Table 4, "Other Residual Solvents (for which no adequate toxicological data was found)". Table 4 substances have no Permitted Daily Exposure assigned, and the chapter's own text says manufacturers should supply justification for residual levels of these solvents. The pharmacopoeia declines to hand anyone a number for TFA.
Any TFA limit on a peptide certificate is therefore a house specification, not a compendial one. That is not a defect in the document. It is a reason to ask whose specification it is, and against what it was justified.
Why the line exists at all
Because trifluoroacetate is not inert in the assays this material is bought for. Cornish and colleagues (American Journal of Physiology, 1999) measured reduced cell numbers and reduced thymidine incorporation in cultured fetal rat osteoblasts and articular chondrocytes exposed to TFA at 10⁻⁸ to 10⁻⁷ M, and reported proliferation consistently lower with the TFA salts. What that work measured was an effect of the counterion on a cell culture — that is, on the experiment.
The second reason is arithmetic. Counterion is mass on the balance, and so is water: whatever fraction of the powder is trifluoroacetate is a fraction that is not peptide — the same accounting the Karl Fischer line raises from the other direction.
What to ask any supplier, including us
- Is the TFA figure a free-acid limit or a counterion determination?
- What method produced it — ion chromatography, ¹⁹F NMR, HPLC — and against what reference?
- Is a measured result reported, or only "conforms"?
- Is the certificate for the lot I will receive?
A supplier that can answer the first two is describing a measurement. One that treats the difference as pedantry has not made it.
Where our catalog sits
Our published certificates carry a TFA line specified as NMT 0.10% by HPLC, with the result reported as Conforms — no measured percentage on that line. They also do not include a separate identity test such as mass spectrometry, which is the subject of the first piece in this series.
The certificate quoted throughout is the GHK-Cu one, COA-PBL-010326-GHKCU, and like every certificate it documents the lot it names and no other. GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine), characterized in dermal fibroblast and extracellular matrix research; the listing is at www.primesciencesupply.com/products/ghk-cu-100. Certificate availability and level of detail vary by product and by lot, and every item we list carries a ≥98% purity specification by HPLC-UV.
If a line on one of our documents is unclear, write to [email protected] and we will tell you what the paper says — including where it says nothing.
Research Use Only. Not for human or veterinary use. These products are not drugs and have not been approved by the FDA for any purpose. These statements have not been evaluated by the FDA. Prime Science Supply does not provide guidance on preparation, administration, or dosage.